Metabolic Health Digest
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Obesity and Polycystic ovary syndrome (PCOS) are individually responsible for infertility. Adiposity has a strong effect on distinct PCOS phenotypes and it affects the...
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2•4 mg for weight management: a randomised, controlled, phase 1b trial
Cagrilintide is a long-acting amylin analogue, and semaglutide 2•4 mg is a glucagon-like peptide-1 analogue. Both the drugs have been investigated as options for...
Bisoprolol was Associated with Better Cardiac Outcomes in Hemodialysis Patients – A Comparison with Carvedilol
Introduction Patients with end-stage renal disease undergoing maintenance dialysis (MHD) are often prescribed with beta-blockers for several prophylactic and therapeutic indications. However, the evidence...
Dr. Arvind Argikar: Guest Editor for May 2021
This month’s issue on metabolic health digest is unique as this edition provides an elaborate understanding of COVID-19 and discusses guidelines for better application...